XML 34 R14.htm IDEA: XBRL DOCUMENT

Subsequent Events	9 Months Ended
Subsequent Events	Sep. 30, 2013
Subsequent Event [Abstract]
Subsequent Events	Note 8 - Subsequent Events S-4 Effective And Shareholders Meeting The SEC declared our registration statement on Form S-4 effective on October 29, 2013, and we have set December 3, 2013 as the date for the shareholders meeting to consider and vote upon the proposed merger with Theraclone.